Histopathologic and physiologic effect of overlapping vs single coronary stents: impact of stent evolution

References

• Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2;349(14):1315–1323. PubMed PMID: 14523139; eng.
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002 Jun 6;346(23):1773–1780. PubMed PMID: 12050336; eng.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015 Mar 26;372(13):1213–1222. PubMed PMID: 25775087; eng.
   PubMed Web of Science ®Google Scholar
• Hecht HS, Polena S, Jelnin V, et al. Stent gap by 64-detector computed tomographic angiography relationship to in-stent restenosis, fracture, and overlap failure. J Am Coll Cardiol. 2009 Nov 17;54(21):1949–1959. PubMed PMID: 19909876; eng.
   PubMed Web of Science ®Google Scholar
• Kereiakes DJ, Wang H, Popma JJ, et al. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol. 2006 Jul 4;48(1):21–31. PubMed PMID: 16814644; eng.
   PubMed Web of Science ®Google Scholar
• Raber L, Juni P, Loffel L, et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol. 2010 Mar 23;55(12):1178–1188. PubMed PMID: 20298923; eng.
   PubMed Web of Science ®Google Scholar
• Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. PubMed PMID: 8041413; eng.
   PubMed Web of Science ®Google Scholar
• Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25;331(8):496–501. PubMed PMID: 8041414; eng.
   PubMed Web of Science ®Google Scholar
• Carrozza JP Jr., Kuntz RE, Fishman RF, et al. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993 Mar 1;118(5):344–349. PubMed PMID: 8430980; eng.
   PubMed Web of Science ®Google Scholar
• Kastrati A, Elezi S, Dirschinger J, et al. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol. 1999 Jun 15;83(12):1617–1622. PubMed PMID: 10392864; eng.
   PubMed Web of Science ®Google Scholar
• Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999 Jan 5–12;99(1):44–52. PubMed PMID: 9884378; eng.
   PubMed Web of Science ®Google Scholar
• Farb A, Weber DK, Kolodgie FD, et al. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002 Jun 25;105(25):2974–2980. PubMed PMID: 12081990; eng.
   PubMed Web of Science ®Google Scholar
• Teirstein PS, Massullo V, Jani S, et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation. 1999 Jan 19;99(2):243–247. PubMed PMID: 9892590; eng.
   PubMed Web of Science ®Google Scholar
• Lincoff AM, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation. 1994 Oct;90(4):2070–2084. PubMed PMID: 7923695; eng.
   PubMed Web of Science ®Google Scholar
• Marx SO, Jayaraman T, Go LO, et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 1995 Mar;76(3):412–417. PubMed PMID: 7532117; eng.
   PubMed Web of Science ®Google Scholar
• Gallo R, Padurean AJayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999;99(16):2164-2170.
   PubMed Web of Science ®Google Scholar
• Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001 Jan 16;103(2):192–195. PubMed PMID: 11208675; eng.
   PubMed Web of Science ®Google Scholar
• Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987 Mar 19;316(12):701–706. . PubMed PMID: 2950322; eng.
   PubMed Web of Science ®Google Scholar
• Garasic JM, Edelman ER, Squire JC, et al. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 2000 Feb 22;101(7):812–818. PubMed PMID: 10683357; eng.
   PubMed Web of Science ®Google Scholar
• Palmaz JC, Bailey S, Marton D, et al. Influence of stent design and material composition on procedure outcome. J Vasc Surg. 2002 Nov;36(5):1031–1039. PubMed PMID: 12422115; eng.
   PubMed Web of Science ®Google Scholar
• Siewiorek GM, Finol EA, Wholey MH. Clinical significance and technical assessment of stent cell geometry in carotid artery stenting. Journal Endovascular Therapy: Official J Inter Soc Endovascular Specialists. 2009 Apr;16(2):178–188. . PubMed PMID: 19456193; PubMed Central PMCID: PMC5621709. eng.
   PubMed Web of Science ®Google Scholar
• Nakano M, Otsuka F, Yahagi K, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013 Nov;34(42):3304–3313. PubMed PMID: 23824827; PubMed Central PMCID: PMC3819590. eng.
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992 Feb;19(2):267–274. PubMed PMID: 1732351; eng.
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Holmes DR Jr., Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992 Nov 1;20(5):1284–1293. PubMed PMID: 1401633; eng.
   PubMed Web of Science ®Google Scholar
• Welt FGP, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1769–1776. PubMed PMID: 12426203; eng.
   PubMed Web of Science ®Google Scholar
• Carter AJ, Farb A, Gould KE, et al. The degree of neointimal formation after stent placement in atherosclerotic rabbit iliac arteries is dependent on the underlying plaque. Cardiovasc Pathology: Official J Soc Cardiovasc Pathol. 1999 Mar-Apr;8(2):73–80. PubMed PMID: 10724504; eng.
   PubMed Web of Science ®Google Scholar
• Chaabane C, Otsuka F, Virmani R, et al. Biological responses in stented arteries. Cardiovasc Res. 2013 Jul 15;99(2):353–363. . PubMed PMID: 23667187; eng.
   PubMed Web of Science ®Google Scholar
• Carter AJ, Laird JR, Farb A, et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol. 1994 Nov 1;24(5):1398–1405. PubMed PMID: 7930266; eng.
   PubMed Web of Science ®Google Scholar
• Kuntz RE, Safian RD, Carrozza JP, et al. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992 Dec;86(6):1827–1835. PubMed PMID: 1451255; eng.
   PubMed Web of Science ®Google Scholar
• Kuntz RE, Gibson CM, Nobuyoshi M, et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 1993 Jan;21(1):15–25. PubMed PMID: 8417056; eng.
   PubMed Web of Science ®Google Scholar
• Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature. 1969 Sep 13;223(5211):1159–1160. PubMed PMID: 5810692; eng.
   PubMed Web of Science ®Google Scholar
• Jimenez JM, Davies PF. Hemodynamically driven stent strut design. Ann Biomed Eng. 2009 Aug;37(8):1483–1494. . PubMed PMID: 19472055; PubMed Central PMCID: PMC2819751. eng.
   PubMed Web of Science ®Google Scholar
• Kolandaivelu K, Swaminathan R, Gibson WJ, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation. 2011 Apr 5;123(13):1400–1409. PubMed PMID: 21422389; PubMed Central PMCID: PMC3131199. eng.
   PubMed Web of Science ®Google Scholar
• Yau JW, Teoh H, Verma S Endothelial cell control of thrombosis. BMC Cardiovasc Disord. 2015 Oct 19;15:130. PubMed PMID: 26481314; PubMed Central PMCID: PMC4617895. eng.doi: 10.1186/s12872-015-0124-z.
   PubMed Web of Science ®Google Scholar
• Kawamoto H, Ruparelia N, Tanaka A, et al. Bioresorbable scaffolds for the management of coronary bifurcation lesions. JACC Cardiovascular Interventions. 2016 May 23;9(10):989–1000. PubMed PMID: 27198679; eng.
   PubMed Web of Science ®Google Scholar
• Balakrishnan B, Tzafriri AR, Seifert P, et al. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation. 2005 Jun 7;111(22):2958–2965. PubMed PMID: 15927969; eng.
   PubMed Web of Science ®Google Scholar
• Hwang CW, Levin AD, Jonas M, et al. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation. 2005 Apr 5;111(13):1619–1626. PubMed PMID: 15795325; eng.
   PubMed Web of Science ®Google Scholar
• Shinke T, Li J, Chen JP, et al. High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries. Circ Cardiovasc Interventions. 2008 Aug;1(1):28–35. PubMed PMID: 20031652; eng.
   PubMed Web of Science ®Google Scholar
• Rikhtegar F, Wyss C, Stok KS, et al. Hemodynamics in coronary arteries with overlapping stents. J Biomech. 2014 Jan 22;47(2):505–511. PubMed PMID: 24275438; eng.
   PubMed Web of Science ®Google Scholar
• Zhou J, Li YS, Chien S. Shear stress-initiated signaling and its regulation of endothelial function. Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2191–2198. . PubMed PMID: 24876354; PubMed Central PMCID: PMC4169328. eng.
   PubMed Web of Science ®Google Scholar
• Thondapu V, Bourantas CV, Foin N, et al. Biomechanical stress in coronary atherosclerosis: emerging insights from computational modelling. Eur Heart J. 2017 Jan 7;38(2):81–92. PubMed PMID: 28158723; eng.
   PubMed Web of Science ®Google Scholar
• Chiastra C, Migliavacca F, Martinez MA, et al. On the necessity of modelling fluid-structure interaction for stented coronary arteries. J Mech Behav Biomed Mater. 2014 Jun;34:217–230. PubMed PMID: 24607760; eng.
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Edelman ER, Carter A, et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002 Oct 1;106(14):1867–1873. PubMed PMID: 12356643; eng.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 2001 Sep 4;104(10):1188–1193. PubMed PMID: 11535578; eng.
   PubMed Web of Science ®Google Scholar
• Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 2001 May 8;103(18):2289–2295. PubMed PMID: 11342479; eng.
   PubMed Web of Science ®Google Scholar
• Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation. 2001 Jul 24;104(4):473–479. PubMed PMID: 11468212; eng.
   PubMed Web of Science ®Google Scholar
• Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol. 2000 Dec;36(7):2325–2332. PubMed PMID: 11127480; eng.
   PubMed Web of Science ®Google Scholar
• Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005 Jul 12;112(2):270–278. PubMed PMID: 15998681; eng.
   PubMed Web of Science ®Google Scholar
• Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation. 2009 Jul 14;120(2):141–9, 1–2. PubMed PMID: 19564562; eng.
   Web of Science ®Google Scholar
• Wilson GJ, Huibregtse BA, Stejskal EA, et al. Vascular response to a third generation everolimus-eluting stent. EuroIntervention: Journal EuroPCR Collaboration with Working Group Interventional Cardiology European Society Cardiology. 2010 Sep;6(4):512–519. PubMed PMID: 20884440; eng.
   PubMed Web of Science ®Google Scholar
• Otsuka F, Cheng Q, Yahagi K, et al. Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt model. JACC Cardiovascular Interventions. 2015 Aug 17;8(9):1248–1260. PubMed PMID: 26292590; eng.
   PubMed Web of Science ®Google Scholar
• Virmani R, editor. Metallic platforms with bioabsorable polymers: potential advantages and pitfalls of bioabsorbable polymers. TCT 2016. 2016. Washington D.C. Available from: https://www.tctmd.com/slide/potential-advantages-and-pitfalls-bioabsorbable-polymers
   Google Scholar
• Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007 May 8;115(18):2435–2441. PubMed PMID: 17438147; eng.
   PubMed Web of Science ®Google Scholar
• Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007 Mar 8;356(10):1009–1019. PubMed PMID: 17296822; eng.
   PubMed Web of Science ®Google Scholar
• James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009 May 7;360(19):1933–1945. PubMed PMID: 19420363; eng.
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018 Jan 14;39(3):213–260. PubMed PMID: 28886622; eng.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American college of cardiology/american heart association task force on clinical practice guidelines. J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243–1275. PubMed PMID: 27751237; eng.
   PubMed Web of Science ®Google Scholar
• Binder RK, Luscher TF. Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding? Eur Heart J. 2015 May 21;36(20):1207–1211. . PubMed PMID: 25838437; eng.
   PubMed Web of Science ®Google Scholar
• Nakano M, Yahagi K, Otsuka F, et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coll Cardiol. 2014 Jun 17;63(23):2510–2520. PubMed PMID: 24768883; eng.
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Farb A, et al. Drug eluting stents: are human and animal studies comparable? Heart. 2003 Feb;89(2):133–138. PubMed PMID: 12527658; PubMed Central PMCID: PMC1767527. eng.
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Vorpahl M, Finn AV, et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovascular Imaging. 2009 May;2(5):625–628. PubMed PMID: 19442951; eng.
   PubMed Web of Science ®Google Scholar
• Otsuka F, Vorpahl M, Nakano M, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014 Jan 14;129(2):211–223. PubMed PMID: 24163064; PubMed Central PMCID: PMC3915802. eng.
   PubMed Web of Science ®Google Scholar
• Habib A, Karmali V, Polavarapu R, et al. Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-alpha activation and disruption of the p120-vascular endothelial cadherin interaction. Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2425–2431. PubMed PMID: 23887639; PubMed Central PMCID: PMC3827918. eng.
   PubMed Web of Science ®Google Scholar
• Leong DP, Dundon BK, Puri R, et al. Very late stent fracture associated with a sirolimus-eluting stent. Heart Lung Circ. 2008 Oct;17(5):426–428. PubMed PMID: 17728185; eng.
   PubMed Web of Science ®Google Scholar
• Shite J, Matsumoto D, Yokoyama M Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J. 2006 Jun;27(12):1389. PubMed PMID: 16246830; eng.
   PubMedGoogle Scholar
• Nakazawa G, Finn AV, Vorpahl M, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009 Nov 17;54(21):1924–1931. PubMed PMID: 19909872; eng.
   PubMed Web of Science ®Google Scholar
• Kan J, Ge Z, Zhang JJ, et al. Incidence and clinical outcomes of stent fractures on the basis of 6,555 Patients and 16,482 drug-eluting stents from 4 centers. JACC Cardiovascular Interventions. 2016 Jun 13;9(11):1115–1123. PubMed PMID: 27009464; eng.
   PubMed Web of Science ®Google Scholar
• Ellis SG, Savage M, Fischman D, et al. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. initial results of a multicenter experience. Circulation. 1992 Dec;86(6):1836–1844. PubMed PMID: 1451256; eng.
   PubMed Web of Science ®Google Scholar
• Serruys PW, Foley DP, Suttorp MJ, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol. 2002 Feb 6;39(3):393–399. PubMed PMID: 11823075; eng.
   PubMed Web of Science ®Google Scholar
• Minutello RM, Bhagan S, Feldman D, et al. Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents. Am J Cardiol. 2006 Feb 15;97(4):499–501. PubMed PMID: 16461045; eng.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Chico JL, Raber L, Regar E, et al. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography. Am Heart J. 2013 Jul;166(1):83–94. PubMed PMID: 23816026; eng.
   PubMed Web of Science ®Google Scholar
• Ichikawa M, Bando K, Kijima Y. Angioscopic observation of extremely late arterial repair after intracoronary implantation of the first-generation sirolimus-eluting stents. Int J Cardiol. 2017 Mar 1;230:488–492.
   PubMed Web of Science ®Google Scholar
• Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovascular Interventions. 2010 May;3(5):531–539. PubMed PMID: 20488410; eng.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Mauri L, O’Shaughnessy C, et al. Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interventions. 2009 Apr;2(2):133–139. PubMed PMID: 20031706; eng.
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. Jama. 2005 Sep 14;294(10):1215–1223. PubMed PMID: 16160130; eng.
   PubMed Web of Science ®Google Scholar
• Stone GW, Midei M, Newman W, et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the clinical evaluation of the xience V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions (SPIRIT) III trial. Circulation. 2009 Feb 10;119(5):680–686. PubMed PMID: 19171853; eng.
   PubMed Web of Science ®Google Scholar
• Hiromasa T, Kuramitsu S, Shinozaki T, et al. Impact of total stent length after cobalt chromium everolimus-eluting stent implantation on 3-year clinical outcomes. Catheterization Cardiovascular Interventions: Official Journal Society Cardiac Angiography Interventions. 2017 Feb 1;89(2):207–216. PubMed PMID: 26910036; eng.
   PubMed Web of Science ®Google Scholar
• Kitabata H, Loh JP, Pendyala LK, et al. Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents. Am J Cardiol. 2013 Oct 15;112(8):1093–1098. PubMed PMID: 23827397; eng.
   PubMed Web of Science ®Google Scholar
• O’Sullivan CJ, Stefanini GG, Raber L, et al. Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention: Journal EuroPCR Collaboration with Working Group Interventional Cardiology European Society Cardiology. 2014 Jan 22;9(9):1076–1084. PubMed PMID: 24064474; eng.
   PubMed Web of Science ®Google Scholar
• Ortega-Paz L, Brugaletta S, Giacchi G, et al. Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention: Journal EuroPCR Collaboration with Working Group Interventional Cardiology European Society Cardiology. 2017 Aug 4;13(5):e557–e563. PubMed PMID: 28242584; eng.
   PubMed Web of Science ®Google Scholar
• Farooq V, Vranckx P, Mauri L, et al. Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart. 2013 May;99(9):626–633. PubMed PMID: 23468513; eng.
   PubMed Web of Science ®Google Scholar
• Park SH, Rha SW, Shin WY, et al. Real-world comparison of angiographic and 2-year clinical outcomes between first and second generation drug-eluting stents in patients received overlapping stents. Eur Heart J. 2013;34(Suppl_1). Available from: https://academic.oup.com/eurheartj/article/34/suppl_1/P3032/2861609
   Google Scholar
• Otake H, Honda Y, Yamasaki M, et al. Vascular response to overlapping everolimus-eluting stents. - Comparison with paclitaxel-eluting stents. Circ Journal: Official Journal Jpn Circ Soc. 2010 May;74(5):1023–1025. PubMed PMID: 20424338; eng.
   PubMed Web of Science ®Google Scholar
• Sarno G, Lagerqvist B, Nilsson J, et al. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR. J Am Coll Cardiol. 2014 Jul 8;64(1):16–24. PubMed PMID: 24998123; eng.
   PubMed Web of Science ®Google Scholar
• Lee M, Hiremath S, Zambahari R, et al. One-year outcomes of percutaneous coronary intervention with the 38-mm resolute zotarolimus-eluting stent. Am J Cardiol. 2013 Nov 1;112(9):1335–1341. PubMed PMID: 23953695; eng.
   PubMed Web of Science ®Google Scholar
• Sgueglia GA, Belloni F, Summaria F, et al. One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 study. Catheterization Cardiovascular Interventions: Official Journal Society Cardiac Angiography Interventions. 2015 Feb 1;85(2):218–224. PubMed PMID: 24824088; eng.
   PubMed Web of Science ®Google Scholar
• Mori N, Okamoto N, Tanaka A, et al. Comparison of angiographic and 1-year outcomes between a long single stent and overlapping double stents in patients with newer-generation drug-eluting stents for long narrowings. Am J Cardiol. 2016 Jun 1;117(11):1724–1728. PubMed PMID: 27062939; eng.
   PubMed Web of Science ®Google Scholar
• Secco GG, Tebaldi M, Parisi R, et al. One-year clinical outcomes of forty-eight millimeter everolimus-eluting stent implanted in very long lesions: a propensity-matched comparison (The FREIUS Study). J Invasive Cardiol. 2018 Apr;30(4):133–137. PubMed PMID: 29610443; eng.
   PubMed Web of Science ®Google Scholar
• Farooq V, Serruys PW, Heo JH, et al. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. JACC Cardiovascular Interventions. 2013 May;6(5):523–532. PubMed PMID: 23702016; eng.
   PubMed Web of Science ®Google Scholar
• Koppara T, Cheng Q, Yahagi K, et al. Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents. Circ Cardiovasc Interventions. 2015 Jun;8(6):e002427. PubMed PMID: 26022535; eng.
   PubMed Web of Science ®Google Scholar
• Ellis SG, Kereiakes DJ, Metzger DC, et al. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med. 2015 Nov 12;373(20):1905–1915. PubMed PMID: 26457558; eng.
   PubMed Web of Science ®Google Scholar
• Wykrzykowska JJ, Kraak RP, Hofma SH, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med. 2017 Jun 15;376(24):2319–2328. PubMed PMID: 28402237; eng.
   PubMed Web of Science ®Google Scholar
• Kereiakes DJ, Ellis SG, Metzger C, et al. 3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III Trial. J Am Coll Cardiol. 2017 Dec 12;70(23):2852–2862. PubMed PMID: 29100702; eng.
   PubMed Web of Science ®Google Scholar
• Ellis SG, Steffenino G, Kereiakes DJ, et al. Clinical, angiographic, and procedural correlates of acute, subacute, and late absorb scaffold thrombosis. JACC Cardiovascular Interventions. 2017 Sep 25;10(18):1809–1815. PubMed PMID: 28935071; eng.
   PubMed Web of Science ®Google Scholar
• Yamaji K, Ueki Y, Souteyrand G, et al. Mechanisms of very late bioresorbable scaffold thrombosis: the INVEST Registry. J Am Coll Cardiol. 2017 Nov 7;70(19):2330–2344. PubMed PMID: 29096803; eng.
   PubMed Web of Science ®Google Scholar